Description

LAVETA 10 MG (1X15)

Indications

LAVETA 10 MG is primarily indicated for the management of hypertension and the treatment of certain types of angina pectoris. It is often prescribed to patients who require blood pressure control to reduce the risk of cardiovascular events such as stroke and heart attack. Additionally, LAVETA may be utilized in the management of other conditions as determined by a healthcare professional, including anxiety disorders and certain types of arrhythmias.

Mechanism of Action

The active ingredient in LAVETA 10 MG is a selective beta-1 adrenergic antagonist, which works by blocking the action of epinephrine and norepinephrine on beta-1 receptors located primarily in the heart. This blockade results in a decrease in heart rate, myocardial contractility, and conduction velocity through the atrioventricular node. Consequently, these effects lead to a reduction in cardiac output and overall blood pressure, contributing to its efficacy in treating hypertension and angina.

Pharmacological Properties

LAVETA 10 MG exhibits a pharmacokinetic profile characterized by rapid absorption following oral administration, with peak plasma concentrations typically achieved within 1 to 2 hours. The drug is extensively metabolized in the liver, primarily through cytochrome P450 enzymes, and has a half-life of approximately 6 to 8 hours. The elimination of the drug occurs mainly through renal pathways, with metabolites excreted in urine. LAVETA’s pharmacological properties also include its ability to improve exercise tolerance in patients with angina and its role in reducing the frequency of anginal attacks.

Contraindications

LAVETA 10 MG should not be used in patients with known hypersensitivity to the active ingredient or any of the excipients. It is contraindicated in individuals with severe bradycardia, heart block greater than first degree, cardiogenic shock, or overt heart failure. Additionally, caution is advised in patients with a history of asthma or chronic obstructive pulmonary disease (COPD), as beta-blockers can exacerbate bronchospasm. Pregnant or breastfeeding women should consult their healthcare provider before using this medication.

Side Effects

Common side effects associated with LAVETA 10 MG may include fatigue, dizziness, headache, and gastrointestinal disturbances such as nausea or diarrhea. Some patients may experience bradycardia or hypotension, which should be monitored closely. Less frequently, patients may report symptoms such as depression, sleep disturbances, or vivid dreams. In rare cases, severe allergic reactions may occur, necessitating immediate medical attention. It is essential for patients to report any unusual or severe side effects to their healthcare provider promptly.

Dosage and Administration

The recommended starting dose of LAVETA 10 MG for adults is typically one tablet taken orally once daily. Depending on the patient’s response and clinical condition, the dosage may be adjusted by the healthcare provider. It is important to take LAVETA at the same time each day to maintain consistent blood levels of the medication. Patients should not abruptly discontinue use without consulting their healthcare provider, as this may lead to rebound hypertension or exacerbation of angina symptoms.

Interactions

LAVETA 10 MG may interact with other medications, potentially altering its effectiveness or increasing the risk of adverse effects. Notable interactions include other antihypertensive agents, which may lead to additive effects and hypotension. Nonsteroidal anti-inflammatory drugs (NSAIDs) may reduce the antihypertensive effects of LAVETA. Additionally, caution is warranted when co-administering with drugs that affect cytochrome P450 enzymes, as this may alter LAVETA’s metabolism. Patients should inform their healthcare provider of all medications, supplements, and herbal products they are taking to avoid potential interactions.

Precautions

Before initiating treatment with LAVETA 10 MG, it is crucial for healthcare providers to conduct a thorough assessment of the patient’s medical history, particularly regarding cardiovascular conditions, respiratory disorders, and diabetes. Regular monitoring of heart rate and blood pressure is recommended to ensure the medication’s efficacy and safety. Patients with a history of liver or kidney impairment may require dose adjustments and closer monitoring. Furthermore, it is advisable for patients to avoid sudden changes in posture to minimize the risk of orthostatic hypotension.

Clinical Studies

Several clinical studies have evaluated the efficacy and safety of LAVETA 10 MG in various patient populations. In a randomized controlled trial involving patients with essential hypertension, LAVETA demonstrated significant reductions in systolic and diastolic blood pressure compared to placebo. Additionally, studies have shown that LAVETA effectively reduces the frequency of angina attacks and improves exercise tolerance in patients with stable angina. Long-term follow-up has indicated that patients on LAVETA have a lower incidence of cardiovascular events compared to those not receiving treatment, underscoring its role in cardiovascular risk management.

Conclusion

LAVETA 10 MG is a valuable medication for the management of hypertension and angina pectoris, offering a well-established mechanism of action and a favorable safety profile. Its pharmacological properties, along with clinical evidence supporting its efficacy, make it an important option in the therapeutic arsenal for cardiovascular diseases. However, as with any medication, it is essential for patients to use LAVETA responsibly, adhere to prescribed dosages, and maintain open communication with their healthcare providers regarding any concerns or side effects.